MENU
+Compare
AXGN
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$18.09
Change
-$0.34 (-1.84%)
Capitalization
348.67M

AXGN Axogen Forecast, Technical & Fundamental Analysis

a provider of products and technologies for peripheral nerve reconstruction and regeneration

AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AXGN with price predictions
Jan 14, 2025

AXGN in downward trend: price expected to drop as it breaks its higher Bollinger Band on January 10, 2025

AXGN broke above its upper Bollinger Band on January 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AXGN moved out of overbought territory on January 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 10, 2025. You may want to consider a long position or call options on AXGN as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on January 13, 2025. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where AXGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.582) is normal, around the industry mean (23.475). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.139) is also within normal values, averaging (41.274).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AXGN is expected to report earnings to fall 62.86% to 2 cents per share on March 04

Axogen AXGN Stock Earnings Reports
Q4'24
Est.
$0.03
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.11
Q1'24
Missed
by $0.04
Q4'23
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of 7 cents, beating the estimate of 0 cents. With 668.75K shares outstanding, the current market capitalization sits at 348.67M.
A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
428
Web
https://www.axogeninc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

AXGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with ICUI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.84%
ICUI - AXGN
39%
Loosely correlated
-1.32%
CERS - AXGN
36%
Loosely correlated
-1.65%
VMD - AXGN
34%
Loosely correlated
-0.24%
VCYT - AXGN
32%
Poorly correlated
-1.27%
SMLR - AXGN
32%
Poorly correlated
+11.06%
More